Category Archives: Pharmaceuticals

Featured Stories
Three Injured, Long Island Railroad Train Hits Car on Tracks

Three Injured When Long Island Railroad Train Hits Car on Tracks

3 people, injured on Wednesday at 1:20 p.m. when a LIRR train hit a livery cab on the tracks west of Wyandanch station. The train engineer, who suffered a shoulder injury.

Read More

Actos Bladder Cancer Lawsuits Continue, New Complaint Filed by Tennessee Resident

Actos bladder cancer lawsuits continue, with a new complaint filed by a resident of Tennessee. The national law firm, Parker Waichman LLP, represents the Tennessee man who alleges that Actos caused his bladder cancer.

Read More

EMA Seeks Stronger Pradaxa Guidance for Bleeding Side Effects

Regulators in Europe have again asked Boehringer Ingelheim, the manufacturer of the blood thinner Pradaxa, to update the drug’s label with additional information regarding Pradaxa bleeding side effects. According to the European Medicines Agency (EMA), the new guidance should include more specific information on when Pradaxa must not be used, ...

Read More

Study Suggests Hormonal Contraceptives Linked to Brain Tumor

Study Suggests Hormonal Contraceptives Linked to Increased Brain Tumor Risk

A study of Danish women of reproductive age suggests that long-term use of hormonal contraceptives is associated with an increased risk of brain tumors.

Read More

Johnson & Johnson Facing More Metal-on-Metal Hip Implant Woes, as DePuy Pinnacle Complaints Rise

Having already spent around $3 billion on its DePuy Orthopaedics ASR hip implant recall, Johnson & Johnson is facing another potential debacle involving a metal-on-metal version of its Pinnacle Hip Replacement System. According to a report from Reuters, Johnson & Johnson and its DePuy unit already face some 1,600 metal-on-metal ...

Study Finds Metal-on-Metal Hip Implants Associated with High Incidence of Pseudotumors

Yet another study is adding to concerns about the potential dangers associated with metal-on-metal hip implants. The study, published in the Journal of Bone and Joint Surgery, found that large diameter metal-on-metal total hip replacement may be associated with a substantially higher incidence of pseudotumor formation.

Read More

West Virginia Man Claims Metal-on-Metal DePuy Pinnacle Hip Replacement Led to Pain, Elevated Cobalt Levels

A West Virginia man fitted with a metal-on-metal version of DePuy Orthopaedics’ Pinnacle Hip Implant System has filed suit against the company and its parent, Johnson & Johnson, alleging the device caused him to suffer pain and elevated cobalt levels. The Plaintiff is being represented by the national law ...

Read More

Majority of Metal-on-Metal Hip Implant Failures Occur within Two Years, Study Finds

A newly published metal-on-metal hip replacement study is reporting that the majority of failures occur early, within two years of surgery. The study, published in the journal Orthopedics, is just the latest to indicate that close follow-up of metal-on-metal hip implant patients is warranted.

Read More

DeflateGate’s Effects Impact Legal Gambling and the Economy

DeflateGate’s Effects Impact Legal Gambling and the Economy

The NFL has initiated a probe into the New England Patriots following allegations that the team intentionally used overly deflated footballs.

Read More

New Study Links Metal-on-Metal Hip Replacement Corrosion with Adverse Local Tissue Reactions

Yet another study is pointing to potential dangers posed by metal-on-metal hip implants. This time, an article published in the Journal of Arthroplasty is reporting corrosion in the head taper junction was more likely to occur in patients with 36-mm diameter metal-on-metal hip replacement, compared to those with the same ...

Read More

Increased Risk of Bone Fractures with Invokana and Invokamet XR

Despite a multitude of warnings for a drug taken for treatment of type 2 diabetes, the U.S. Food and Drug Administration (FDA) has expanded indications for Invokamet (canagliflozin and metformin). Invokamet along with Invokana (canagliflozin), carry warnings for adverse reactions … Continue reading

Posted in Health Concerns, Pharmaceuticals |

Popular Heartburn Medications Linked to Increased Risk of Death

Drugs to relieve heartburn and acid-reflux are among the best selling drugs in the country, used by millions of Americans annually in both prescription and non-prescription strength. Excess acid can cause stomach ulcers and damage to the esophagus. A reduction … Continue reading

Posted in Health Concerns, Pharmaceuticals, Proton Pump Inhibitors |

Soliris Vaccination Raises Risk for Meningococcal Disease

People who have received eculizumab (brand name Soliris) are at high risk (1,000 to 2,000-fold greater), for invasive meningococcal disease compared to the general United States population. Life-threatening and fatal infections have occurred in some patients treated with Soliris. These … Continue reading

Posted in Health Concerns, Pharmaceuticals |

Propecia-Related Sexual Dysfunction Linked to Depression

The active ingredient in Propecia is finasteride, known to effectively block the hormone responsible for male pattern baldness, a common genetic form of hair loss. However, a number of studies suggest it may also have damaging effects on a man’s … Continue reading

Posted in Health Concerns, Pharmaceuticals |

FDA Warning Letters for Bodybuilding Products Containing Steroid-Like Substances

On June 20, 2017, the U.S. Food and Drug Administration (FDA) posted warning letters to Flex Fitness/Big Dan’s Fitness, AndroPharm, and Hardcore Formulations for illegally marketing products labeled as containing steroid and steroid-like substances and promoted to increase muscle mass and strength. The products are … Continue reading

Posted in Defective Products, Health Concerns, Pharmaceuticals |

Another Try for MDL for PPI Lawsuits – Kidney Damage Allegations

Proton pump inhibitors (PPIs) such as Nexium, Prilosec, and Prevacid are drugs used in the treatment of acid reflux or heartburn. Plaintiffs have filed lawsuits alleging that these medications caused kidney injuries and have filed a motion to consolidate 172 … Continue reading

Posted in Health Concerns, Nexium, Pharmaceuticals |

More Than 400 Cases in Viagra-Melanoma Multidistrict Litigation

As of May 15, 2017, 428 men are plaintiffs in a Viagra (sildenafil) multidistrict product liability litigation in U.S. District Court for the Northern District of California. The suit alleges that the “little blue pill,” manufactured by Pfizer, is connected … Continue reading

Posted in Health Concerns, Pharmaceuticals, Viagra |

Pancreatitis Risk for Some Patients Taking Viberzi

Viberzi (eluxadoline), a drug to treat irritable bowel syndrome with diarrhea (IBS-D) has drawn a warning from the U.S. Food and Drug Administration (FDA) following the deaths of two patients. The patients who died did not have their gallbladders and … Continue reading

Posted in Health Concerns, Pharmaceuticals |

Xarelto Manufacturer Leads Spending for Physicians’ Favor

Xarelto Manufacturer Leads Spending for Physicians’ Favor

The public-interest news organization ProPublica issued a new report that indicates manufacturers spent more in 2015 on physician payments for Xarelto than any other drug. These payments were not for research, but for things like consulting, meals, travel, promotional speaking, … Continue reading

Posted in Pharmaceuticals | Tagged , , , , |

Risperdal Litigation is Second Largest Mass Tort in Philadelphia

Risperdal Litigation is Second Largest Mass Tort in PA

Mass Tort Contains Risperdal Gynecomastia Lawsuits Lawsuits alleging the antipsychotic drug Risperdal caused gynecomastia continue to mount against Johnson & Johnson’s Janssen unit. In fact, Risperdal litigation accounts for most of the mass tort growth in Philadelphia’s Complex Litigation Center. … Continue reading

Posted in Pharmaceuticals | Tagged , , , , |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.